Published in Thromb Res on November 15, 1984
Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet (1978) 3.74
The composition of food consumed by Greenland Eskimos. Acta Med Scand (1976) 2.27
Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr (1975) 2.06
The composition of the Eskimo food in north western Greenland. Am J Clin Nutr (1980) 1.99
Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet (1971) 1.77
Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease. J Thromb Haemost (2011) 1.61
Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation (2001) 1.61
Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus. Thromb Res (2010) 1.59
Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet (1979) 1.56
Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy (1986) 1.51
Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Med Scand (1972) 1.49
Dose-response studies on the effect of n-3 polyunsaturated fatty acids on lipids and haemostasis. Thromb Haemost (1990) 1.47
Plasma 6-keto-PGF1 alpha, thromboxane B2 and PGE2 during diabetic ketoacidosis. Prostaglandins Leukot Essent Fatty Acids (1990) 1.41
The influence of trans fatty acids on health: a report from the Danish Nutrition Council. Clin Sci (Lond) (1995) 1.41
[Hyperlipidemia in children]. Ugeskr Laeger (1993) 1.40
Alpha-linolenic acid and heart rate variability. Nutr Metab Cardiovasc Dis (2000) 1.40
[Homocysteine and cardiovascular disease]. Ugeskr Laeger (2001) 1.39
Rapid screening of increased bile acid deconjugation and bile acid malabsorption by means of the glycine-l-(14C) cholylglycine assay. Scand J Gastroenterol (1973) 1.33
Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ (1996) 1.22
The effect of N-6 and N-3 polyunsaturated fatty acids on hemostasis, blood lipids and blood pressure. Thromb Haemost (1983) 1.14
Fast food: unfriendly and unhealthy. Int J Obes (Lond) (2007) 1.13
Dietary fat and thrombosis. Lancet (1978) 1.12
Assessment of ileal function by abdominal counting of the retention of a gamma emitting bile acid analogue. Gut (1982) 1.12
Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. Am J Clin Nutr (1999) 1.07
Linolenate-derived polyunsaturated fatty acids and prevention of atherosclerosis. Nutr Rev (1986) 1.07
A hypothesis on the development of acute myocardial infarction in Greenlanders. Scand J Clin Lab Invest Suppl (1982) 1.06
The apolipoprotein E polymorphism in Greenland Inuit in its global perspective. Hum Genet (1996) 1.05
Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time. Heart (2009) 1.04
Mortality from ischaemic heart disease and cerebrovascular disease in Greenland. Int J Epidemiol (1988) 1.02
Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease. Thromb Haemost (2013) 0.98
Evaluation of the applicability of the SeHCAT test in the investigation of patients with diarrhoea. Scand J Gastroenterol (1988) 0.97
Intake of ruminant trans fatty acids in the Danish population aged 1-80 years. Eur J Clin Nutr (2006) 0.92
The bleeding tendency in Greenland Eskimos. Dan Med Bull (1980) 0.91
Acetylsalicylic acid, bleeding time and age. Thromb Res (1980) 0.91
The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial. Eur J Clin Invest (1992) 0.91
Lipid metabolism, atherogenesis, and haemostasis in Eskimos: the role of the prostaglandin-3 family. Haemostasis (1979) 0.90
[n-3 polyunsaturated fatty acids, heart rate variability and ventricular arrhythmias in post-AMI-patients. A clinical controlled trial]. Ugeskr Laeger (1997) 0.89
Plasma lipids and lipoproteins in patients with myocardial infarction and in a control material. Acta Med Scand (1970) 0.89
Omega-3 fatty acids. Current status in cardiovascular medicine. Drugs (1994) 0.88
Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy. Diabetologia (1992) 0.88
n-3 fatty acids in health and disease. Introduction. J Intern Med Suppl (1989) 0.88
Dietary supplementation with n-3 polyunsaturated fatty acids and human platelet function: a review with particular emphasis on implications for cardiovascular disease. J Intern Med Suppl (1989) 0.88
Effects of potassium and glutamate on brain cortex slices: uptake and release of glutamic and other amino acids. J Neurochem (1971) 0.87
Platelets and atherosclerosis. A review on the role of platelets in atherosclerosis with special reference to the role of polyunsaturated 20 carbon fatty acids. Dan Med Bull (1980) 0.87
Coronary heart disease in Greenland Inuit: a paradox. Implications for western diet patterns. Arctic Med Res (1989) 0.87
Marine oils and thrombogenesis. Prog Lipid Res (1982) 0.87
Platelet - vessel wall interaction: influence of diet. Philos Trans R Soc Lond B Biol Sci (1981) 0.86
Magnesium inhibits platelet activity--an in vitro study. Thromb Haemost (1996) 0.86
Platelet number and volume during myocardial infarction in relation to infarct size. Acta Med Scand (1986) 0.86
Familial functional antithrombin III deficiency. Scand J Haematol (1980) 0.86
N-3 fatty acids from fish and coronary artery disease: implications for public health. Public Health Nutr (2000) 0.86
Magnesium inhibits platelet activity--an infusion study in healthy volunteers. Thromb Haemost (1996) 0.86
Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol (1997) 0.86
ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007. Eur Heart J (2008) 0.85
Protein C assays in uremia. Thromb Res (1989) 0.85
Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males. Atherosclerosis (1989) 0.84
Long-term supplementation with n-3 fatty acids, II: Effect on neutrophil and monocyte chemotaxis. Scand J Clin Lab Invest (1992) 0.84
The effect of dialyser membrane material on intradialytic changes in platelet count, platelet aggregation, circulating platelet aggregates and antithrombin III. Scand J Urol Nephrol (1985) 0.84
Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. Eur J Clin Nutr (2004) 0.84
Decreased interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids. Clin Rheumatol (1992) 0.84
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost (2013) 0.84
The prostacyclin/thromboxane balance is favourably shifted in Greenland Eskimos. Prostaglandins (1986) 0.83
The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease. Thromb Haemost (2014) 0.83
Remote ischemic preconditioning reduces thrombus formation in the rat. J Thromb Haemost (2012) 0.83
Haemophilic patients with hepatitis C have higher viral load compared to other well-defined patient groups. J Viral Hepat (2000) 0.83
n-3 fatty acids and renal diseases. Am J Kidney Dis (1994) 0.83
Diagnostic value of ascitic fluid cholesterol levels in the prediction of malignancy. Scand J Gastroenterol (1988) 0.83
An improved holder for transfer of brain slices during in vitro incubation. Exp Brain Res (1970) 0.82
Recurrent thrombosis in a patient with factor XII deficiency. Acta Haematol (1980) 0.82
The absence of factor II in a child with systemic lupus erythematosus. Acta Paediatr Scand (1978) 0.82
Cholesterol kinetics in patients with cholesterol gallstones before and during chenodeoxycholic acid treatment. Scand J Gastroenterol (1974) 0.82
Myocardial infarction centres: the way forward. Heart (2005) 0.82
Plasma cholesterol concentration in Caucasian Danes and Greenland West-coast Eskimos. Dan Med Bull (1977) 0.81
n-3 fatty acids and leukocyte chemotaxis. Effects in hyperlipidemia and dose-response studies in healthy men. Arterioscler Thromb (1991) 0.81
The effect of fish oil on lipids, coagulation and fibrinolysis in patients with angina pectoris. Artery (1988) 0.80
Stability of prostacyclin in plasma. Lancet (1979) 0.80
Effect of trans fatty acid intake on abdominal and liver fat deposition and blood lipids: a randomized trial in overweight postmenopausal women. Nutr Diabetes (2011) 0.80
Cigarette smoking shortens the bleeding time. Thromb Res (1983) 0.80
Metabolism of D-[U-14C]ribose in rat tissues. J Neurochem (1971) 0.80
Cigarette smoking and its effects on the platelet-vessel wall interaction. Scand J Clin Lab Invest (1984) 0.80
Early administration of intravenous magnesium inhibits arterial thrombus formation. Arterioscler Thromb Vasc Biol (1997) 0.80
Heart rate variability and n-3 fatty acids in patients with chronic renal failure--a pilot study. Clin Nephrol (1998) 0.79
Serum angiotensin-converting enzyme increases during hemodialysis. Evidence for injury of the pulmonary vascular endothelium? Nephron (1985) 0.79
Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation. Pharmacol Res Commun (1979) 0.79
No effect of a very low dose of n-3 fatty acids on monocyte function in healthy humans. Scand J Clin Lab Invest (1996) 0.79
Dietary supplementation with omega-3-polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-1 beta content but not monokine secretion in healthy and insulin-dependent diabetic individuals. Scand J Immunol (1991) 0.79
omega 3 fatty acids. From eskimos to clinical cardiology--what took us so long? World Rev Nutr Diet (2001) 0.79
Plasma concentration levels of apolipoprotein A-I, apolipoprotein B and lipoprotein (a) in Greenland Inuit (Eskimos). J Intern Med (1992) 0.79
Apolipoprotein(a) in insulin-dependent diabetic patients with and without diabetic nephropathy. Scand J Clin Lab Invest (1992) 0.79
Fish oil and ischaemic heart disease in Greenland. Lancet (1988) 0.78
Enalapril and exercise-induced hyperkalemia. A study of patients randomized to double-blind treatment with enalapril or placebo after acute myocardial infarction. Int J Cardiol (1992) 0.78
Letter: Tranexamic acid: a new approach to autoimmune disease? Lancet (1975) 0.78
The effects of n-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia. Atherosclerosis (1993) 0.78
High on-treatment platelet reactivity and P2Y12 antagonists in clinical trials. Thromb Haemost (2012) 0.78
[The importance of trans-fatty acids for health. Update 2001]. Ugeskr Laeger (2001) 0.78
Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid. Angiology (1993) 0.78